NM_025137.4:c.2066A>G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP3BP6
The NM_025137.4(SPG11):c.2066A>G(p.Glu689Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000118 in 1,612,948 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E689K) has been classified as Uncertain significance.
Frequency
Consequence
NM_025137.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 11Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina, G2P
- amyotrophic lateral sclerosis type 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Charcot-Marie-Tooth disease axonal type 2XInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SPG11 | NM_025137.4 | c.2066A>G | p.Glu689Gly | missense_variant, splice_region_variant | Exon 10 of 40 | ENST00000261866.12 | NP_079413.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000460  AC: 7AN: 152238Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251070 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.00000822  AC: 12AN: 1460710Hom.:  0  Cov.: 32 AF XY:  0.00000688  AC XY: 5AN XY: 726754 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000460  AC: 7AN: 152238Hom.:  0  Cov.: 32 AF XY:  0.0000134  AC XY: 1AN XY: 74378 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.2066A>G (p.E689G) alteration is located in exon 10 (coding exon 10) of the SPG11 gene. This alteration results from a A to G substitution at nucleotide position 2066, causing the glutamic acid (E) at amino acid position 689 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hereditary spastic paraplegia 11    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at